Literature DB >> 27930407

Bowel Damage in Crohn's Disease: Direct Comparison of Ultrasonography-based and Magnetic Resonance-based Lemann Index.

Antonio Rispo1, Nicola Imperatore, Anna Testa, Pierpaolo Mainenti, Giovanni Domenico De Palma, Gaetano Luglio, Simone Maurea, Olga Maria Nardone, Nicola Caporaso, Fabiana Castiglione.   

Abstract

BACKGROUND: The Lémann index (LI), calculated by magnetic resonance (MR) or computed tomography enterography in association with endoscopy, was developed to assess bowel damage (BD) in Crohn's disease (CD). Our aim was to investigate the concordance between ultrasonography-based Lèmann index (US-LI) and magnetic resonance-based Lèmann index (MR-LI).
METHODS: We prospectively evaluated all consecutive patients with CD referred to our IBD Unit. All patients had undergone endoscopy, US and MR within 1 month. US-LI and MR-LI were calculated by scoring previous surgery, location, extension, and intestinal complications. Furthermore, we evaluated the association between LI and: CD duration, Harvey-Bradshaw index, and other relevant clinical features. In accordance with recent literature, an LI >4.8 was considered indicative of BD.
RESULTS: Seventy-one patients with CD were examined. About CD location, 36% showed ileal disease (L1), 10% showed colonic CD (L2), whereas 54% had an ileocolonic disease (L3). Moreover, 27% of patients presented a noncomplicated behavior (B1), 45% had almost one stricture (B2), whereas 28% showed penetrating CD (B3). Perianal CD was observed in 16% of subjects, whereas 40% had undergone previous surgery. MR-LI and US-LI were 6.62 (95% confidence interval, 4.2-9.7) and 6.04 (95% confidence interval, 3.6-9.2), respectively (r = 0.90; P < 0.001), with 35 patients (49%) showing an LI indicative of BD. No significant correlation was evident between LI and Harvey-Bradshaw index (P = 0.9), whereas a significant correlation was found between both US-LI/MR-LI and CD duration (P = 0.01).
CONCLUSIONS: US-LI shows high concordance with MR-LI and could be considered a good option for assessing BD in CD by using a highly available and relatively inexpensive procedure.

Entities:  

Mesh:

Year:  2017        PMID: 27930407     DOI: 10.1097/MIB.0000000000000980

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  12 in total

1.  Influence of Genetics, Immunity and the Microbiome on the Prognosis of Inflammatory Bowel Disease (IBD Prognosis Study): the protocol for a Copenhagen IBD Inception Cohort Study.

Authors:  Mohamed Attauabi; Gorm Roager Madsen; Flemming Bendtsen; Anne Vibeke Wewer; Rune Wilkens; Johan Ilvemark; Nora Vladimirova; Annette Bøjer Jensen; Frank Krieger Jensen; Sanja Bay Hansen; Hartwig Roman Siebner; Yousef Jesper Wirenfeldt Nielsen; Jakob M Møller; Henrik S Thomsen; Simon Francis Thomsen; Helene Andrea Sinclair Ingels; Klaus Theede; Trine Boysen; Jacob T Bjerrum; Christian Jakobsen; Maria Dorn-Rasmussen; Sabine Jansson; Yiqiu Yao; Ewa Anna Burian; Frederik Trier Møller; Viktoria Fana; Charlotte Wiell; Lene Terslev; Mikkel Østergaard; Kristina Bertl; Andreas Stavropoulos; Jakob B Seidelin; Johan Burisch
Journal:  BMJ Open       Date:  2022-06-27       Impact factor: 3.006

Review 2.  Impact of therapies on bowel damage in Crohn's disease.

Authors:  Gionata Fiorino; Cristiana Bonifacio; Mariangela Allocca; Silvio Danese
Journal:  United European Gastroenterol J       Date:  2020-02-20       Impact factor: 4.623

3.  New Predictive Equations for Estimating Resting Energy Expenditure in Adults With Crohn's Disease.

Authors:  Maurizio Marra; Iolanda Cioffi; Delia Morlino; Olivia Di Vincenzo; Maria Carmen Pagano; Nicola Imperatore; Lucia Alfonsi; Lidia Santarpia; Fabiana Castiglione; Luca Scalfi; Fabrizio Pasanisi
Journal:  JPEN J Parenter Enteral Nutr       Date:  2020-02-03       Impact factor: 4.016

4.  Association between Health-Related Quality of Life and Nutritional Status in Adult Patients with Crohn's Disease.

Authors:  Iolanda Cioffi; Nicola Imperatore; Olivia Di Vincenzo; Lidia Santarpia; Antonio Rispo; Maurizio Marra; Anna Testa; Franco Contaldo; Fabiana Castiglione; Fabrizio Pasanisi
Journal:  Nutrients       Date:  2020-03-11       Impact factor: 5.717

5.  Evaluation of nutritional adequacy in adult patients with Crohn's disease: a cross-sectional study.

Authors:  Iolanda Cioffi; Nicola Imperatore; Olivia Di Vincenzo; Maria Carmen Pagano; Lidia Santarpia; Lucienne Pellegrini; Anna Testa; Maurizio Marra; Franco Contaldo; Fabiana Castiglione; Fabrizio Pasanisi
Journal:  Eur J Nutr       Date:  2020-02-18       Impact factor: 5.614

6.  Efficacy of early intervention on the bowel damage and intestinal surgery of Crohn's disease, based on the Lémann index.

Authors:  Mingming Zhu; Qi Feng; Xitao Xu; Yuqi Qiao; Zhe Cui; Yunqi Yan; Zhihua Ran
Journal:  BMC Gastroenterol       Date:  2020-12-11       Impact factor: 3.067

7.  Magnetic resonance enterography and bowel ultrasonography in Saudi Arabian patients with Crohn's disease: A correlation study.

Authors:  Rani Ahmad; Ahmed Abduljabbar; Mohammad Wazzan; Rawan Thabit; Mahmoud Mosli; Omar I Saadah
Journal:  Saudi J Gastroenterol       Date:  2022 May-Jun       Impact factor: 3.214

8.  Bowel Damage at Diagnosis Using the Lémann Index Score in Saudi Arabian Patients With Crohn's Disease.

Authors:  Hajar Halawani; Ahmed Abduljabbar; Mohammad Wazzan; Dalia Abdulmonem Hashem; Cedric Baumann; Amandine Luc; Laurent Peyrin-Biroulet; Omar I Saadah; Mahmoud Mosli
Journal:  Cureus       Date:  2020-10-12

Review 9.  Cross-Sectional Imaging Instead of Colonoscopy in Inflammatory Bowel Diseases: Lights and Shadows.

Authors:  Ludovico Alfarone; Arianna Dal Buono; Vincenzo Craviotto; Alessandra Zilli; Gionata Fiorino; Federica Furfaro; Ferdinando D'Amico; Silvio Danese; Mariangela Allocca
Journal:  J Clin Med       Date:  2022-01-12       Impact factor: 4.241

Review 10.  Role of Intestinal Ultrasound in the Management of Patients with Inflammatory Bowel Disease.

Authors:  Aranzazu Jauregui-Amezaga; Jordi Rimola
Journal:  Life (Basel)       Date:  2021-06-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.